Billiontoone, Inc. (NASDAQ:BLLN – Get Free Report) reached a new 52-week low during trading on Wednesday . The stock traded as low as $64.74 and last traded at $65.7970, with a volume of 164184 shares. The stock had previously closed at $70.20.
Analysts Set New Price Targets
BLLN has been the topic of a number of analyst reports. Zacks Research upgraded shares of Billiontoone to a “hold” rating in a report on Tuesday, December 2nd. Guggenheim reissued a “buy” rating and set a $120.00 target price on shares of Billiontoone in a research report on Thursday, March 5th. JPMorgan Chase & Co. decreased their target price on Billiontoone from $150.00 to $145.00 and set an “overweight” rating for the company in a research note on Wednesday, December 10th. Weiss Ratings started coverage on Billiontoone in a report on Tuesday, February 3rd. They issued a “sell (d)” rating for the company. Finally, Piper Sandler reiterated an “overweight” rating on shares of Billiontoone in a research note on Wednesday, December 10th. Six equities research analysts have rated the stock with a Buy rating, three have issued a Hold rating and one has assigned a Sell rating to the stock. Based on data from MarketBeat, the stock presently has a consensus rating of “Moderate Buy” and an average price target of $129.57.
Check Out Our Latest Analysis on Billiontoone
Billiontoone Stock Performance
Billiontoone (NASDAQ:BLLN – Get Free Report) last posted its earnings results on Wednesday, March 4th. The company reported $0.11 EPS for the quarter, topping analysts’ consensus estimates of $0.04 by $0.07. The firm had revenue of $96.05 million for the quarter, compared to analyst estimates of $85.85 million. The company’s quarterly revenue was up 113.0% compared to the same quarter last year.
Institutional Investors Weigh In On Billiontoone
Several large investors have recently modified their holdings of BLLN. Rossby Financial LCC acquired a new position in shares of Billiontoone in the 4th quarter valued at $25,000. Wells Fargo & Company MN acquired a new stake in Billiontoone during the 4th quarter worth $76,000. Smartleaf Asset Management LLC purchased a new position in Billiontoone during the 4th quarter worth $80,000. Nano Cap New Millennium Growth Fund L P acquired a new position in Billiontoone in the fourth quarter valued at $82,000. Finally, Renaissance Capital LLC purchased a new stake in shares of Billiontoone in the fourth quarter valued at about $201,000.
About Billiontoone
BillionToOne (NASDAQ: BLLN) is a molecular diagnostics company that develops and commercializes high-precision genetic testing solutions based on single-molecule counting technology. The company’s platform is designed to detect and quantify rare genetic variants and chromosomal abnormalities from cell-free DNA, with a primary focus on applications in prenatal screening and other clinical genetic tests where sensitivity and specificity at very low allele fractions are critical.
BillionToOne’s offerings center on assay development and clinical testing workflows that enable non-invasive prenatal testing (NIPT) and targeted molecular diagnostics.
See Also
- Five stocks we like better than Billiontoone
- The gold chart Wall Street is terrified of…
- What a Former CIA Agent Knows About the Coming Collapse
- Elon Musk already made me a “wealthy man”
- Unlocked: Elon Musk’s Next Big IPO
- 1,500 Banks Just Handed the Fed Your Bank Account
Receive News & Ratings for Billiontoone Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Billiontoone and related companies with MarketBeat.com's FREE daily email newsletter.
